X
FDA approves Teva’s migraine drug, decision due on Lilly’s rival
https://pharmaphorum.com/news/fda-approves-tevas-migraine-drug-decision-due-on-lillys-rival/
Teva
Teva holding off launch of opioid addiction drug
Drugmaker awaiting outcome of separate court case
Regeneron/Teva pain drug fasinumab on target in phase 3
Pfizer and Eli Lilly are competitors in NGF research
FDA rejects Teva/Celltrion biosimilars
Regulator cites issues with manufacturing plant
Sosei see Teva pipeline cull as an opportunity
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
